Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, October 15, 2008, 8:32PM ET - U.S. Markets Closed. Dow Down 7.87% Nasdaq Down 8.47%
Vaso Active Pharmaceuticals Inc. (VAPH.OB)At 9:30AM ET: 0.10  Down 0.01 (9.09%)  
MORE ON VAPH.OB
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Vaso Active Pharmaceuticals Inc.
99 Rosewood Drive
Suite 260
Danvers, MA 01923
United States - Map
Phone: 978-750-1991
Web Site: http://www.vasoactive.us

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Full Time Employees:5

BUSINESS SUMMARY 
Vaso Active Pharmaceuticals, Inc. focuses on the commercialization, marketing, and sale of over-the-counter (OTC) pharmaceutical products that incorporate a proprietary PENtoCORE technology. It also owns the OTC worldwide license to use and practice vaso active lipid encapsulated technology, a patchless, lipid-based delivery system. The company’s products include Osteon, an OTC external analgesic, to provide temporary relief from the muscular skeletal pain associated with arthritis; A-R Extreme, an OTC external analgesic, to provide temporary relief from the muscle and joint pain associated with athletic activity; and Termin8, an OTC antifungal lotion to treat athlete's foot. It also develops acne treatment, analgesic utilizing ibuprofen, first aid treatments, hand and body lotions, psoriasis treatment, and toenail fungus treatment products. Vaso Active Pharmaceuticals distributes its products to chain drug and grocery stores. The company was founded in 2001 and is based in Danvers, Massachusetts. Vaso Active Pharmaceuticals, Inc. is a subsidiary of BioChemics, Inc.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Vaso Active Pharmaceuticals Inc.


    KEY EXECUTIVES 
     PayExercised
    Mr. Joseph Frattaroli , 46
    Acting Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer and Sec.
    N/A N/A
    Dr. Stephen G. Carter Ph.D., 55
    Chief Scientific Officer, VP
    N/A N/A
    Mr. John J. Masiz Esq., 48
    Consultant
    N/A N/A
    Dollar amounts are as of 31-Dec-07 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis